Medicure Company Profile (CVE:MPH)

About Medicure (CVE:MPH)

Medicure logoMedicure Inc. (Medicure) is a pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. The Company operates in the biopharmaceutical industry segment. The Company's primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban hydrochloride) owned by its subsidiary, Medicure International, Inc. and distributed in the United States and its territories through the Company's United States subsidiary, Medicure Pharma, Inc. AGGRASTAT, a glycoprotein IIb/IIIa inhibitor (GPI), is used for the treatment of acute coronary syndrome (ACS). The Company is also engaged in the development of TARDOXAL for neurological disorders, such as Tardive Dyskinesia (TD). The Company has completed Phase IIa stage of development for TARDOXAL. The Company is also developing Transdermal AGGRASTAT, a cure for acute cardiology. Transdermal AGGRASTAT is in preclinical-stage of development.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: CVE:MPH
  • CUSIP: N/A
  • Web: N/A
  • Market Cap: C$113.38 million
  • Outstanding Shares: 15,532,000
Average Prices:
  • 52 Week Range: C$5.20 - C$10.67
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
Sales & Book Value:
  • Annual Revenue: C$37.78 million
  • Price / Sales: 3.00
  • Book Value: C$2.37 per share
  • Price / Book: 3.08
  • EBIDTA: C$12.14 million
  • Average Volume: 22,921 shs.
  • Short Ratio: 0.03

Frequently Asked Questions for Medicure (CVE:MPH)

What is Medicure's stock symbol?

Medicure trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MPH."

Who are some of Medicure's key competitors?

How do I buy Medicure stock?

Shares of Medicure and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How much does a share of Medicure stock cost?

One share of Medicure stock can currently be purchased for approximately C$7.30.

Analyst Ratings

Consensus Ratings for Medicure (CVE:MPH) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Medicure (CVE:MPH)
DateFirmActionRatingPrice TargetDetails
5/4/2016M PartnersReiterated RatingBuyView Rating Details
1/12/2016MackieBoost Price TargetBuyC$8.00View Rating Details
(Data available from 5/25/2015 forward)


Earnings History for Medicure (CVE:MPH)
No earnings announcements for this company have been tracked by


Earnings Estimates for Medicure (CVE:MPH)
2017 EPS Consensus Estimate: $0.96
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.09$0.09$0.09
Q2 20171$0.27$0.27$0.27
Q3 20171$0.29$0.29$0.29
Q4 20171$0.31$0.31$0.31
(Data provided by Zacks Investment Research)


Dividend History for Medicure (CVE:MPH)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Medicure (CVE:MPH)
Insider Trades by Quarter for Medicure (CVE:MPH)
Insider Trades by Quarter for Medicure (CVE:MPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/3/2017Graeme William MerchantInsiderBuy1,000C$7.07C$7,070.00
5/2/2017Albert David FriesenDirectorBuy1,100C$7.59C$8,349.00
3/17/2016Albert David FriesenDirectorBuy1,100C$5.55C$6,105.00
3/16/2016Graeme William MerchantInsiderBuy1,650C$6.40C$10,560.00
3/11/2016Graeme William MerchantInsiderBuy1,500C$6.30C$9,450.00
3/8/2016Graeme William MerchantInsiderSell6,300C$7.01C$44,163.00
9/9/2015Elliott International CapitalInsiderSell1,426,002C$2.98C$4,249,485.96
1/7/2015Albert David FriesenDirectorBuy2,900C$2.01C$5,829.00
(Data available from 1/1/2013 forward)


Headline Trends for Medicure (CVE:MPH)
Latest Headlines for Medicure (CVE:MPH)
DateHeadline logoAnalysts Set Expectations for Medicure Inc's Q1 2017 Earnings (MPH) - May 25 at 7:18 AM logoM Partners Comments on Medicure Inc's FY2017 Earnings (MPH) - May 24 at 8:32 AM logoMedicure Becomes Oversold (MPH) - May 23 at 6:10 PM logoInput Capital (INP) Shares Cross 2% Yield Mark - May 19 at 11:16 AM logoMedicure Q1 Results and Conference Call Dates - May 19 at 11:16 AM logoAutoCanada (ACQ) Shares Cross 2% Yield Mark - May 16 at 6:24 PM logoNotable Two Hundred Day Moving Average Cross - SII - May 15 at 6:00 PM logoOversold Conditions For Badger Daylighting (BAD) - May 13 at 8:48 AM logoCWX Crosses Above Key Moving Average Level - May 12 at 1:51 AM logoAltius Minerals Is Now Oversold (ALS) - May 10 at 6:42 PM logoOversold Conditions For Stingray Digital Group (RAY-A) - May 9 at 6:17 PM logoRSI Makes Bullish Cross Above Critical Moving Average - May 5 at 11:58 PM logoRSI Alert: Alaris Royalty (AD) Now Oversold - May 4 at 6:41 PM logoACQ.CA Makes Notable Cross Below Critical Moving Average - May 3 at 5:40 PM logoSilvercorp Metals (SVM) Shares Cross Below 200 DMA - May 1 at 5:36 PM logoM Partners Weighs in on Medicure Inc's FY2017 Earnings (MPH) - May 1 at 9:20 AM logoCBL.CA Dividend Yield Pushes Past 7% - April 29 at 8:24 AM logoMedicure Reports Financial Results for Quarter and Year Ended December 31, 2016 - PR Newswire (press release) - April 28 at 7:39 PM logoFC Crosses Above 7% Yield Territory - April 28 at 9:11 AM logoLBS Crosses Above 12% Yield Territory - April 26 at 11:44 PM logoReminder - Atrium Mortgage Investment (AI) Goes Ex-Dividend Soon - April 25 at 5:55 AM logoSupremex (SXP) Shares Cross 5% Yield Mark - April 21 at 6:27 PM logoMedicure Inc Expected to Post FY2017 Earnings of $0.65 Per Share (MPH) - April 21 at 1:06 PM logoMedicure Getting Very Oversold (MPH) - April 19 at 6:40 PM logoRelative Strength Alert For Gluskin Sheff (GS) - April 17 at 5:52 PM logoARE Makes Notable Cross Below Critical Moving Average - April 13 at 6:20 PM logoResearch Reports Initiated on Healthcare Stocks Kane Biotech, Eastwood Bio-Medical Canada, iCo Therapeutics, and ... - - April 13 at 8:34 AM logoCNL Crosses Above Key Moving Average Level - April 13 at 12:33 AM logoSJR-A Crosses Below Key Moving Average Level - April 12 at 7:37 AM logoNorth American Palladium (PDL) Shares Cross Above 200 DMA - April 7 at 7:06 PM logoMedicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017 - Yahoo Finance - March 31 at 9:34 AM logoForm 6-K MEDICURE INC For: Mar 29 - March 29 at 7:15 PM logoMEDICURE INC. - - March 24 at 6:36 PM logoReminder - Morguard Real Estate Investment Trust (MRT-UN) Goes Ex-Dividend Soon - December 12 at 6:44 PM logoMedicure Closes Acquisition of Majority Interest in Apicore - MarketWatch - December 2 at 6:19 PM logoCrown Capital Partners Completes $60.0 Million Term Loan with Medicure Inc. - November 18 at 9:04 AM logoMedicure Exercises Option to Acquire Majority Interest in Apicore - November 18 at 9:04 AM logoReminder - Morguard North American Residential Real Estate Investment Trust (MRG-UN) Goes Ex-Dividend Soon - October 26 at 6:15 PM logoReminder - InterRent Real Estate Investment Trust (IIP-UN) Goes Ex-Dividend Soon - September 27 at 10:49 AM logoMedicure Reports Second Quarter 2016 Financial Results - August 11 at 9:26 AM logoMedicure Inc. (MPH.V) - February 24 at 10:28 AM logoUndervalued And Underfollowed; Medicure Is My Favorite Pharma Small Cap - February 17 at 10:03 AM logoMedicure To Present At Cantech Investment Conference - January 22 at 9:43 AM



Medicure (MPH) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by Staff